✦ LIBER ✦

A Multigene Assay for Predicting the Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

✍ Scribed by Cristofanilli, Massimo

Book ID: 122581487
Publisher: Elsevier Science
Year: 2005
Tongue: English
Weight: 53 KB
Volume: 16
Category: Article
ISSN: 1043-321X
DOI: 10.1016/S1043-321X(05)80168-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A Multigene Assay to Predict Recurrence

A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

✍ Paik, Soonmyung; Shak, Steven; Tang, Gong; Kim, Chungyeul; Baker, Joffre; Cronin 📂 Article 📅 2004 🏛 Massachusetts Medical Society 🌐 English ⚖ 132 KB

3–34 A Multigene Assay to Predict Recurr

3–34 A Multigene Assay to Predict Recurrence of Tamoxifen-Treated, Node-Negative Breast Cancer

✍ Kelly, P; Makumbi, FA; Luo, N.; Seedat, YK; Farthing, MJG 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 49 KB

Cost-utility of the 21-gene recurrence s

Cost-utility of the 21-gene recurrence score assay in node-negative and node-positive breast cancer

✍ Nathan W. D. Lamond, Chris Skedgel, Daniel Rayson, Lynn Lethbridge, Tallal Youni 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 462 KB

A Multigene Expression Assay to Predict

A Multigene Expression Assay to Predict Local Recurrence Risk for Ductal Carcinoma In Situ of the Breast

✍ Haffty, B.G. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 52 KB

The Risk of Recurrence in Breast Cancer

The Risk of Recurrence in Breast Cancer Patients Treated with Tamoxifen: Polymorphisms ofCYP2D6andABCB1

✍ L. K. Teh; N. I. Mohamed; M. Z. Salleh; M. Rohaizak; N. S. Shahrun; J. J. Saladi 📂 Article 📅 2011 🏛 American Association of Pharmaceutical Scientists 🌐 English ⚖ 266 KB

Axillary recurrence rate 5 years after n

Axillary recurrence rate 5 years after negative sentinel node biopsy for breast cancer

✍ Y. Andersson; J. de Boniface; P.-E. Jönsson; C. Ingvar; G. Liljegren; L. Bergkvi 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 125 KB 👁 2 views